Myeloid cell–synthesized coagulation factor X dampens antitumor immunity

Authors: Claudine Graf, Petra Wilgenbus, Sven Pagel, Jennifer Pott, Federico Marini, Sabine Reyda, Maki Kitano, Stephan Macher-Göppinger, Hartmut Weiler, Wolfram Ruf

Published: 2019-09-20

DOI: 10.1126/sciimmunol.aaw8405

Source: Full article

---

Abstract

Rivaroxaban, an inhibitor of coagulation factor Xa, promotes antitumor immunity in mice.